Tuvusertib in Astrocytoma With ATRX Mutation
Conditions
Astrocytoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hospital Universitario Son Espases, Palma de Mallorca, Balearic Islands, Spain
Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)Hospital Universitario Vall d'Hebron, Barcelona, Barcelona, Spain
Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)Hospital Clinic de Barcelona, Barcelona, Barcelona, Spain
Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain
Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)Hospital Universitario Virgen de las Nieves, Granada, Granada, Spain
Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)Hospital Universitario Ramón y Cajal, Madrid, Madrid, Spain
Contact: Study coordinator (Responsible person Designated by the Sponsor) · Investigacion@mfar.net · 0034934344412Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Spain
Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)Hospital Clínico Universitario de Salamanca, Salamanca, Salamanca, Spain
Contact: Study coordinator (Resposible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)Hospital Universitario Virgen del Rocío, Seville, Sevilla, Spain
Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)Hospital Clínico Universitario de Valencia - INCLIVA, Valencia, Valencia, Spain
Contact: Study coordinator (Responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (Principal investigator Designated by the Sponsor, MD)
Study leads
Estela Pineda, M.D.; Ph.D.
Study Chair
Medical Oncology, Hospital Clínic de Barcelona
Maria Vieito, M.D.; Ph.D.
Study Chair
Medical Oncology, Hospital Universitari Vall d'Hebrón